IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 275 filers reported holding IMMUNOGEN INC in Q3 2023. The put-call ratio across all filers is 0.37 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,074,046 | -15.3% | 193,702 | +0.7% | 0.01% | 0.0% |
| Q2 2023 | $3,631,324 | +1995.8% | 192,439 | +326.5% | 0.01% | – |
| Q1 2023 | $173,266 | +17226.6% | 45,121 | +8255.7% | 0.00% | – |
| Q1 2019 | $1,000 | -91.7% | 540 | -55.0% | 0.00% | – |
| Q2 2018 | $12,000 | -14.3% | 1,200 | -6.8% | 0.00% | – |
| Q1 2018 | $14,000 | +55.6% | 1,287 | -4.0% | 0.00% | – |
| Q4 2017 | $9,000 | -10.0% | 1,341 | +3.6% | 0.00% | – |
| Q3 2017 | $10,000 | +11.1% | 1,295 | +7.9% | 0.00% | – |
| Q2 2017 | $9,000 | +350.0% | 1,200 | +140.0% | 0.00% | – |
| Q1 2017 | $2,000 | +100.0% | 500 | 0.0% | 0.00% | – |
| Q4 2016 | $1,000 | 0.0% | 500 | 0.0% | 0.00% | – |
| Q3 2016 | $1,000 | – | 500 | +1624.1% | 0.00% | – |
| Q2 2016 | $0 | -100.0% | 29 | -99.9% | 0.00% | -100.0% |
| Q3 2015 | $394,000 | – | 41,052 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 17,503,417 | $277,779,228 | 13.22% |
| Fairmount Funds Management LLC | 5,929,592 | $94,102,625 | 11.32% |
| CM Management, LLC | 500,000 | $7,935,000 | 8.42% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 1,307,435 | $20,748,993 | 6.29% |
| Altium Capital Management LP | 725,000 | $11,505,750 | 6.00% |
| RA Capital Management | 13,322,288 | $211,424,711 | 4.16% |
| TANG CAPITAL MANAGEMENT LLC | 1,500,000 | $23,805,000 | 3.36% |
| BRIDGER MANAGEMENT, LLC | 467,220 | $7,414,781 | 2.73% |
| Birchview Capital, LP | 190,000 | $3,015,300 | 2.57% |
| Boxer Capital, LLC | 2,961,000 | $46,991,070 | 2.50% |